Description
NSE announces the forthcoming listing of Sai Parenterals Limited equity shares under symbol SAIPARENT (ISIN: INE0H9F01037). The exact listing date will be communicated via a separate circular.
Summary
NSE has issued a circular (Ref No: NSE/CML/73553, Circular Ref. No: 0552/2026) informing members about the forthcoming listing of equity shares of Sai Parenterals Limited on the Exchange. The company will trade under the symbol SAIPARENT. The specific listing date has not been announced in this circular and will be communicated through a separate circular.
Key Points
- Company: Sai Parenterals Limited
- Trading Symbol: SAIPARENT
- ISIN: INE0H9F01037
- Exchange: National Stock Exchange of India (NSE)
- Circular Reference: NSE/CML/73553 | Circular Ref. No: 0552/2026
- Listing date to be announced via a separate circular
Regulatory Changes
No regulatory changes are introduced. This is a standard listing notification informing exchange members of an upcoming IPO listing.
Compliance Requirements
All members of the Exchange are required to take note of the forthcoming listing of Sai Parenterals Limited equity shares and prepare accordingly for trading operations once the listing date is confirmed.
Important Dates
- Circular Date: April 01, 2026
- Listing Date: To be announced via a separate circular
Impact Assessment
The listing of Sai Parenterals Limited (SAIPARENT) on NSE will open the stock to exchange-wide trading for the first time. Market participants, particularly those who subscribed to the IPO, should monitor the forthcoming listing date circular. The impact is moderate, affecting IPO investors and traders interested in the pharmaceutical/parenterals sector.
Impact Justification
Standard IPO listing announcement for Sai Parenterals Limited; exact listing date pending a follow-up circular, limiting immediate actionability.